Market Overview:
The global alternative drug delivery systems market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in alternative drug delivery systems. Based on type, the global alternative drug delivery systems market is segmented into nasal, transdermal, transmucosal, and others. The nasal segment is expected to account for the largest share of the global alternative drug delivery systems market in 2018. This segment is projected to grow at a CAGR of 8% during the forecast period from 2018 to 2030. This growth can be attributed to factors such as growing demand for minimally invasive procedures and rising incidence of respiratory diseases. Based on application, the global alternative drug delivery systems market is divided into hospital-based applications and clinic-based applications. The hospital-based applications segment accounted for majority share (64%) of total revenue generated by application segments in 2017 and it will continue its dominance over other application segments throughout forecast period owing high adoption rate across globe followed by clinic based applications which are anticipated witness highest CAGR over next 10 years . Some key players operating in this marketspace include 3M Company (USt), Becton Dickinson & Company (US), Cardinal Health Inc.(US), Medtronic plc.
Product Definition:
Alternative Drug Delivery Systems are methods of drug delivery that differ from the traditional oral, intravenous, intramuscular and subcutaneous routes. These systems include inhalers, transdermal patches, implantable devices and ocular inserts. Alternative drug delivery systems offer several advantages over traditional methods including improved patient compliance, increased bioavailability and decreased side effects.
Nasal:
Nasal drug delivery is a mode of drug administration through the nose. It has gained popularity in recent years due to its safety and non-invasive nature. The nasal route provides faster absorption compared to oral or injectable routes, which may increase patient compliance.
Transdermal:
Transdermal patches are adhesive devices that allow the transmission of drugs through the skin. They are most commonly used for pain management, but they can also be used to deliver medication through other body surfaces such as the scalp, armpit or intravenous sites. The system is based on a reservoir that holds a sufficient amount of drug to be absorbed by the patient's body and then releases it at a specific site according to need.
Application Insights:
The hospital application segment accounted for the largest revenue share in 2016 and is anticipated to maintain its dominance over the forecast period. The rising prevalence of chronic diseases, such as cancer, diabetes and cardiovascular diseases, among others is expected to drive demand for these systems in hospitals. Furthermore, increasing government initiatives towards improving healthcare infrastructure are further likely to benefit market growth.
The other application segment includes non-clinical settings such as offices or homes; however, this segment is expected to witness a decline in demand owing to various factors including costliness compared with clinical settings and unavailability of insurance coverage for these drugs at home or work places. Moreover, there are certain drug delivery systems that cannot be delivered via an alternative route due to their unique structure or properties that render them unsuitable for any other type of drug delivery system delivery methodologies available in the market place. These include transdermal patches (for nicotine replacement therapy) and nasal sprays (for decongestion).
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of key players and high adoption rate for new technologies. The region is expected to maintain its dominance over the forecast period due to increasing R&D investments by companies as well as government initiatives. For instance, in May 2018, Evonik announced funding worth USD X million for research on novel drug delivery systems at University of California San Diego (UCSD). This initiative was taken with an aim to develop innovative drug delivery systems that can treat cancer using nanotechnology.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast period owing rising healthcare expenditure and improving healthcare infrastructure in countries such as China and India. Moreover, growing awareness about alternative therapies along with economic growth are some other factors driving this regional market forward during the estimated time frame.
Growth Factors:
- Increasing incidence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. According to a study by the World Health Organization (WHO), non-communicable diseases such as cancer, cardiovascular disease, diabetes, and respiratory disorders accounted for 63% of all deaths in 2012. This number is expected to rise to 73% by 2030. The growing incidence of chronic diseases will create a large demand for alternative drug delivery systems that can provide targeted drug delivery and improve patient outcomes.
- Advances in nanotechnology: Nanotechnology has emerged as one of the most promising technologies for developing alternative drug delivery systems. Nanoparticles are tiny particles that have a diameter less than 100 nm. They can be used to deliver drugs directly to specific cells or tissues, which helps reduce side effects and improve patient outcomes. Nanotechnology-based alternative drug delivery systems are being increasingly used in cancer treatment, gene therapy, and other medical applications."
Scope Of The Report
Report Attributes
Report Details
Report Title
Alternative Drug Delivery Systems Market Research Report
By Type
Nasal, Transdermal, Transmucosal, Others
By Application
Hospital, Clinic, Other
By Companies
Lab International, Hospira, Aveva Drug Delivery, SRI international, Alliqua Biomedical, Zosano Pharma, Meros Polymers
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
193
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Alternative Drug Delivery Systems Market Report Segments:
The global Alternative Drug Delivery Systems market is segmented on the basis of:
Types
Nasal, Transdermal, Transmucosal, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Lab International
- Hospira
- Aveva Drug Delivery
- SRI international
- Alliqua Biomedical
- Zosano Pharma
- Meros Polymers
Highlights of The Alternative Drug Delivery Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Nasal
- Transdermal
- Transmucosal
- Others
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Alternative Drug Delivery Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Alternative drug delivery systems are technologies that allow for the safe and effective delivery of drugs to patients. These systems can include various types of implants, patches, injections, and other methods.
Some of the major players in the alternative drug delivery systems market are Lab International, Hospira, Aveva Drug Delivery, SRI international, Alliqua Biomedical, Zosano Pharma, Meros Polymers.
The alternative drug delivery systems market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Alternative Drug Delivery Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Alternative Drug Delivery Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Alternative Drug Delivery Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Alternative Drug Delivery Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Alternative Drug Delivery Systems Market Size & Forecast, 2020-2028
4.5.1 Alternative Drug Delivery Systems Market Size and Y-o-Y Growth
4.5.2 Alternative Drug Delivery Systems Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Nasal
5.2.2 Transdermal
5.2.3 Transmucosal
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Alternative Drug Delivery Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Alternative Drug Delivery Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Nasal
9.6.2 Transdermal
9.6.3 Transmucosal
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Nasal
10.6.2 Transdermal
10.6.3 Transmucosal
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Nasal
11.6.2 Transdermal
11.6.3 Transmucosal
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Nasal
12.6.2 Transdermal
12.6.3 Transmucosal
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Nasal
13.6.2 Transdermal
13.6.3 Transmucosal
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Alternative Drug Delivery Systems Market: Competitive Dashboard
14.2 Global Alternative Drug Delivery Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Lab International
14.3.2 Hospira
14.3.3 Aveva Drug Delivery
14.3.4 SRI international
14.3.5 Alliqua Biomedical
14.3.6 Zosano Pharma
14.3.7 Meros Polymers
